Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis

doi:10.5500/wjt.v12.i3.59

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6898)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

620

WORD

HTML

3817

Figures (1-1)

227

Sum=4747

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

256

Download

578

Sum=834

Publishing Process of This Article

Item

Count

Browse

364

Download

953

Sum=1317

Mar 18, 2022 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Transplant. Mar 18, 2022; 12(3): 59-64
Published online Mar 18, 2022. doi: 10.5500/wjt.v12.i3.59

Open in New Tab Full Size Figure Download Figure

Figure 1 Summary of the factors implicated in the development of recurrent autoimmune hepatitis after liver transplantation. HLA: Human leukocyte antigen.

Citation: Harputluoglu M, Caliskan AR, Akbulut S. Autoimmune hepatitis and liver transplantation: Indications, and recurrent and de novo autoimmune hepatitis. World J Transplant 2022; 12(3): 59-64
URL: https://www.wjgnet.com/2220-3230/full/v12/i3/59.htm
DOI: https://dx.doi.org/10.5500/wjt.v12.i3.59